Evidence map›Paper›PMID 40678441›Full record

ArticleNeurology. Genetics2025

Muscle Biopsy Findings in Valosin-Containing Protein Multisystem Proteinopathy.

Marianela Schiava, Yolande Parkhurst, Matthew Henderson, Tuomo Polvikoski, Manouela V Valtcheva, Ichizo Nishino, Michio Inoue, Yukako Nishimori, Yoshihiko Saito, Tanya Stojkovic and 58 more

Abstract readComment
In one paragraph

Article in Neurology. Genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

68 authors.

Marianela SchiavaThe John Walton Muscular Dystrophy Research Centre, Newcastle University and Newcastle Hospitals NHS Foundation Trusts, Newcastle, United Kingdom.ORCID https://orcid.org/0000-0002-2709-265X
Yolande ParkhurstNHS England HSS for Rare Neuromuscular Diseases, Muscle Immunoanalysis Unit, Newcastle upon Tyne, United Kingdom.ORCID https://orcid.org/0009-0005-4633-0990
Matthew HendersonNHS England HSS for Rare Neuromuscular Diseases, Muscle Immunoanalysis Unit, Newcastle upon Tyne, United Kingdom.ORCID https://orcid.org/0000-0001-5605-1913
Tuomo PolvikoskiThe John Walton Muscular Dystrophy Research Centre, Newcastle University and Newcastle Hospitals NHS Foundation Trusts, Newcastle, United Kingdom.
Manouela V ValtchevaDepartment of Neurology, Washington University School of Medicine, St. Louis, MO.ORCID https://orcid.org/0009-0007-0248-0983
Ichizo NishinoDepartment of Neuromuscular Research, National Center of Neurology and Psychiatry (NCNP), Tokyo, Japan.ORCID https://orcid.org/0000-0001-9452-112X
Michio InoueDepartment of Neuromuscular Research, National Center of Neurology and Psychiatry (NCNP), Tokyo, Japan.ORCID https://orcid.org/0000-0003-2757-3266
Yukako NishimoriDepartment of Neuromuscular Research, National Center of Neurology and Psychiatry (NCNP), Tokyo, Japan.ORCID https://orcid.org/0009-0003-4418-4462
Yoshihiko SaitoDepartment of Neuromuscular Research, National Center of Neurology and Psychiatry (NCNP), Tokyo, Japan.ORCID https://orcid.org/0000-0003-1643-4797
Tanya StojkovicAPHP, Centre de référence des maladies neuromusculaires, Institut de Myologie, Sorbonne Université, APHP, Hôpital Pitié-Salpêtrière, Paris, France.ORCID https://orcid.org/0000-0002-4054-2838
Rocio N Villar-QuilesAPHP, Centre de référence des maladies neuromusculaires, Institut de Myologie, Sorbonne Université, APHP, Hôpital Pitié-Salpêtrière, Paris, France.
Norma Beatriz RomeroAPHP, Centre de référence des maladies neuromusculaires, Institut de Myologie, Sorbonne Université, APHP, Hôpital Pitié-Salpêtrière, Paris, France.ORCID https://orcid.org/0000-0001-7714-0069
Teresinha EvangelistaAPHP, Centre de référence des maladies neuromusculaires, Institut de Myologie, Sorbonne Université, APHP, Hôpital Pitié-Salpêtrière, Paris, France.ORCID https://orcid.org/0000-0002-1329-9131
Edoardo MalfattiAPHP, Neuromuscular Reference Center Nord-Est-Ile-de-France, Henri Mondor Hospital, Université Paris Est, U955, INSERM, Créteil, IMRB, Paris, France.ORCID https://orcid.org/0000-0001-7871-8600
Sarah SouvannanorathAPHP, Neuromuscular Reference Center Nord-Est-Ile-de-France, Henri Mondor Hospital, Université Paris Est, U955, INSERM, Créteil, IMRB, Paris, France.ORCID https://orcid.org/0000-0001-7986-0983
Elena PegoraroDepartment of Neurosciences, University of Padova, Padova, Italy.ORCID https://orcid.org/0000-0002-7740-4156
Pietro RiguzziDepartment of Neurosciences, University of Padova, Padova, Italy.ORCID https://orcid.org/0009-0006-0241-2174
Mauro MonforteDipartimento di Neuroscienze, Organi di Senso e Torace, UOC di Neurologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.ORCID https://orcid.org/0000-0002-4327-6969
Sara BortolaniDipartimento di Neuroscienze, Organi di Senso e Torace, UOC di Neurologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.ORCID https://orcid.org/0000-0002-6472-0563
Eleonora TorchiaDipartimento di Neuroscienze, Organi di Senso e Torace, UOC di Neurologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.ORCID https://orcid.org/0000-0003-1965-6483
Mario SabatelliDipartimento di Neuroscienze, Organi di Senso e Torace, UOC di Neurologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.ORCID https://orcid.org/0000-0001-6635-4985
Giorgio TascaThe John Walton Muscular Dystrophy Research Centre, Newcastle University and Newcastle Hospitals NHS Foundation Trusts, Newcastle, United Kingdom.ORCID https://orcid.org/0000-0003-0849-9144
Volker StraubThe John Walton Muscular Dystrophy Research Centre, Newcastle University and Newcastle Hospitals NHS Foundation Trusts, Newcastle, United Kingdom.ORCID https://orcid.org/0000-0001-9046-3540
Chiara Marini-BettoloThe John Walton Muscular Dystrophy Research Centre, Newcastle University and Newcastle Hospitals NHS Foundation Trusts, Newcastle, United Kingdom.ORCID https://orcid.org/0000-0003-3795-6017
Michela GuglieriThe John Walton Muscular Dystrophy Research Centre, Newcastle University and Newcastle Hospitals NHS Foundation Trusts, Newcastle, United Kingdom.ORCID https://orcid.org/0000-0002-8455-0637
Hakan CetinDepartment of Neurology, Medical University of Vienna, Austria.ORCID https://orcid.org/0000-0001-9009-7261
Ellen GelpiDepartment of Neurology, Medical University of Vienna, Austria.ORCID https://orcid.org/0000-0003-2948-4187
Sigrid KlotzDepartment of Neurology, Medical University of Vienna, Austria.ORCID https://orcid.org/0000-0003-3096-2852
Jan L De BleeckerDepartment of Neurology and Neuromuscular Reference Center, Ghent University Hospital, Ghent, Belgium.
Alicia Alonso-JimenezDepartment of Neurology, Neuromuscular Reference Centre, Antwerp University Hospital, Universiteit Antwerpen, Instituut Born Bunge, Antwerpen, Belgium.ORCID https://orcid.org/0000-0002-2200-9255
Jonathan BaetsDepartment of Neurology, Neuromuscular Reference Centre, Antwerp University Hospital, Universiteit Antwerpen, Instituut Born Bunge, Antwerpen, Belgium.ORCID https://orcid.org/0000-0001-8295-5385
Willem De RidderDepartment of Neurology, Neuromuscular Reference Centre, Antwerp University Hospital, Universiteit Antwerpen, Instituut Born Bunge, Antwerpen, Belgium.ORCID https://orcid.org/0000-0003-2754-5302
Peter De JongheDepartment of Neurology, Neuromuscular Reference Centre, Antwerp University Hospital, Universiteit Antwerpen, Instituut Born Bunge, Antwerpen, Belgium.
Kristl G ClaeysDepartment of Neurology, University Hospitals Leuven, Leuven, Belgium.ORCID https://orcid.org/0000-0001-9937-443X
Dietmar Rudolf ThalExperimental Neurology, Laboratory for Neuropathology, Leuven Brain Institute, Leuven, Belgium.ORCID https://orcid.org/0000-0002-1036-1075
Jorge A BevilacquaDepartment of Neurology and Neurosurgery, Hospital Clínico Universidad de Chile.ORCID https://orcid.org/0000-0002-0525-9308
Sushan LuoDepartment of Neurology, Huashan Hospital Fudan University, Shanghai, China.ORCID https://orcid.org/0000-0002-9033-7568
Wenhua ZhuDepartment of Neurology, Huashan Hospital Fudan University, Shanghai, China.ORCID https://orcid.org/0000-0001-8011-0274
Jie LinDepartment of Neurology, Huashan Hospital Fudan University, Shanghai, China.ORCID https://orcid.org/0000-0001-6351-3389
George PapadimasFirst Department of Neurology, Medical School, Eginition Hospital and National and Kapodistrian University of Athens, Athens, Greece.ORCID https://orcid.org/0000-0003-0163-4091
Constantinos PapadopoulosFirst Department of Neurology, Medical School, Eginition Hospital and National and Kapodistrian University of Athens, Athens, Greece.ORCID https://orcid.org/0000-0001-7633-5032
Eleni Zamba-PapanicolaouFirst Department of Neurology, Medical School, Eginition Hospital and National and Kapodistrian University of Athens, Athens, Greece.ORCID https://orcid.org/0000-0001-7727-9714
Sophia XirouFirst Department of Neurology, Medical School, Eginition Hospital and National and Kapodistrian University of Athens, Athens, Greece.ORCID https://orcid.org/0000-0001-8222-091X
Endre PalDepartment of Neurology, University of Pécs, Pécs, Hungary.ORCID https://orcid.org/0000-0001-6525-0754
Carmelo RodolicoDepartment of Clinical and Experimental Medicine, University of Messina, Messina, Italy.ORCID https://orcid.org/0000-0003-2543-6356
Anna Kostera-PruszczykDepartment of Neurology, Medical University of Warsaw, European Reference Network ERN-NMD, Warsaw, Poland.ORCID https://orcid.org/0000-0002-7309-1914
Biruta KierdaszukDepartment of Neurology, Medical University of Warsaw, European Reference Network ERN-NMD, Warsaw, Poland.
Anna KaminskaDepartment of Neurology, Medical University of Warsaw, European Reference Network ERN-NMD, Warsaw, Poland.
Nuria MuelasDepartment of Neurology, University Hospital La Fe, Valencia, Spain.ORCID https://orcid.org/0000-0002-2349-7481
Juan Jesus VilchezDepartment of Neurology, University Hospital La Fe, Valencia, Spain.ORCID https://orcid.org/0000-0002-0532-2872
Cristina Domínguez-GonzálezCentro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Madrid, Spain.ORCID https://orcid.org/0000-0001-5151-988X
Aurelio Hernandez-LainNeurology Department, Hospital Universitario de Vinalopó, Elche, Spain.ORCID https://orcid.org/0000-0003-1642-4505
Jorge Alonso-PerezNeuromuscular Disease Unit, Neurology Department, Hospital Universitario Nuestra Señora de Candelaria, Instituto de Investigación Sanitaria de Canarias (IISC), Canarias, Spain.ORCID https://orcid.org/0000-0001-8866-5186
Velina Nedkova-HristovaNeurology Department, Bellvitge University Hospital, Bellvitge, Spain.ORCID https://orcid.org/0000-0001-8797-3371
Carlos AledoNeurology Department, Hospital Universitario de Vinalopó, Elche, Spain.ORCID https://orcid.org/0000-0001-7110-5713
Anders OldforsDepartment of Laboratory Medicine, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden.ORCID https://orcid.org/0000-0002-5758-7397
Umesh A BadrisingDepartment of Neurology, Leiden University Medical Centre, Leiden, the Netherlands.ORCID https://orcid.org/0000-0003-0146-2664
Hani KushlafDepartment of Neurology & Rehabilitation Medicine, University of Cincinnati, Cincinnati, OH.ORCID https://orcid.org/0000-0002-3786-1133
Thomas E LloydDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD.ORCID https://orcid.org/0000-0003-4756-3700
Chiseko IkenagaDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD.ORCID https://orcid.org/0000-0003-2264-1696
Lindsay N AlfanoCenter for Gene Therapy, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH.ORCID https://orcid.org/0000-0002-2263-7569
Colin C QuinnNeuromuscular Division, Neurology Department, University of Pennsylvania, Philadelphia, PA.ORCID https://orcid.org/0000-0003-0618-5854
David WalkDepartment of Neurology, University of Minnesota, MN.ORCID https://orcid.org/0000-0001-7941-1993
Matthias VorgerdDepartment of Neurology, University Hospital Bergmannsheil, Heimer Institute for Muscle Research, Bochum, Germany; and.
Conrad WeihlDepartment of Neurology, Washington University School of Medicine, St. Louis, MO.ORCID https://orcid.org/0000-0002-3816-6124
Montse OlivéNeuromuscular Diseases Unit, Neurology Service, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.ORCID https://orcid.org/0000-0001-5727-0165
Jordi Diaz-ManeraThe John Walton Muscular Dystrophy Research Centre, Newcastle University and Newcastle Hospitals NHS Foundation Trusts, Newcastle, United Kingdom.ORCID https://orcid.org/0000-0003-2941-7988
VCP International Study Group

Funding

VCP in myopathy and dementiaR01AG031867 · NIA · WASHINGTON UNIVERSITY · PI CONRAD C WEIHL · 2009 to 2026
$9.1M
Clinical and Translational Studies in Muscle DiseaseK24AR073317 · NIAMS · WASHINGTON UNIVERSITY · PI CONRAD C WEIHL · 2018 to 2026
$1.6M
NIAMS NIH HHS K24 AR073317NIA NIH HHS R01 AG031867
6 · The paper itself

Abstract

Background and Objectives: Valosin Containing Protein-associated multisystem proteinopathy (VCP-MSP) is a progressive, autosomal dominant disorder caused by pathogenic variants in the VCP gene, resulting in a heterogeneous clinical presentation. Muscle biopsy findings are characteristic but not pathognomonic. This study aimed to comprehensively analyse VCP-related myopathology and explore correlations with clinical phenotypes, genetic variants, and disease progression. Methods: Muscle biopsy images and data were collected retrospectively from adults (≥18 years) with pathogenic or likely pathogenic VCP variants enrolled in the VCP Multicentre International Study. Biopsy data were standardized using the "Common Data Elements for Muscle Biopsy Reporting." Variations in biopsy findings were analysed by biopsy site, time from disease onset, the four most common VCP variants, and clinical phenotypes. Result: A total of 112 muscle biopsies were included. Most individuals were male (66.0%). The mean age at biopsy was 53.3 years (SD 10.0), with a mean disease duration of 6.5 years (SD 4.5). The most frequent VCP variant was c.464G>A (p.Arg155His) (18.8%). The top clinical phenotypes were isolated myopathy (37.5%), myopathy with Paget disease of bone (17.9%), and myopathy with motor neuron involvement (13.4%). The vastus lateralis was the most common biopsy site (34.8%), and 91% were open biopsies. Histopathologic findings included atrophic fibres (87.5%), rimmed vacuoles (72.3%), endomysial fibrosis (58.0%), and protein aggregates (51.8%), primarily p62 (60.3%) and VCP (36.2%). Degeneration niches with fibrofatty replacement and atrophic fibres were seen in 33.3% of biopsies without frequency differences by clinical phenotypes. There were no differences in biopsy findings among the 4 most common VCP gene variants, except for the absence of degeneration niches in muscle biopsies of 12 patients with c.277C>T (p.Arg93Cys). MRI data from 30 patients showed fat pockets corresponding to these niches and STIR hyperintensity correlated with inflammatory infiltrates in 42.9%. Concordance between clinical phenotype, biopsy, and neurophysiology was observed in only 49.4% of cases, indicating significant heterogeneity. Discussion: VCP-MSP muscle biopsies consistently show myopathic or mixed patterns with rimmed vacuoles and p62/VCP-positive inclusions, regardless of clinical phenotype, age, or progression. Some lack vacuoles, challenging diagnosis. Discrepancies between clinical, neurophysiology, and biopsy findings should prompt consideration of VCP-MSP to improve detection and management.

Identifiers

PMID40678441
PMCPMC12270496

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.